Nicotinic receptors in human brain: topography and pathology
Open accessAbstract
Brain nicotinic acetylcholine receptors (nAChR) are a class of ligand-gated channels composed of alpha and beta subunits with specific structural, functional and pharmacological properties. They participate in the physiological and behavioural effects of acetylcholine and mediate responses to nicotine. They are associated with numerous transmitter systems and their expression is altered during development and ageing as well as in diseases such as autism, schizophrenia, Alzheimer's disease, Parkinson's disease and Lewy body dementia. Nicotinic receptors containing a number of different subunits are highly expressed during early human development. Disorders believed to be associated with abnormal brain maturation involve deficits in both alpha4beta2, in the case of autism, and alpha7 possibly in addition to alpha4beta2 nAChRs in the case of schizophrenia. In ageing and age-related neurodegenerative disorders nAChR deficits are predominantly associated with alpha4-containing receptors, although some studies also indicate the involvement of alpha3 and alpha7 subunits. Whilst ageing appears to be associated with reductions in subunit mRNA as well as protein expression, in Alzheimer's disease only protein loss is apparent. Nicotinic therapy may be of benefit in a number of neurological conditions, however studies evaluating further both the distribution of specific subunit involvement and the correlation of nAChR deficits with clinical symptoms are required to inform therapeutic strategy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The heteromeric a4b2* subtype and the homomeric a7 are the most prevalent receptor subtypes in the central nervous system.
“The heteromeric a4b2* subtype and the homomeric a7 are the most prevalent receptor subtypes in the central nervous system (Court et al., 2000).”
From Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors (2014) · cites this paper as Court et al., 2000
Cites
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · see citing works
Self-citationSELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565 · see citing works
A rapid radiochemical method for the determination of choline acetyltransferase
Fonnum, F. (1975) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1975.tb11895.x · Cited by 2,358 · see citing works
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · see citing works
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308 · see citing works
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293 · see citing works
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141 · see citing works
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070 · see citing works
Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022 · see citing works
Cholinergic dysfunction in diseases with Lewy bodies
Dodel, R. C., Du, Y.-S., Bales, K., Gao, F., Eastwood, B., Glazier, B., Zimmer, R., Cordell, B., Hake, A., Evans, R., et al. (2000) · Neurology · doi:10.1212/wnl.54.2.407 · Cited by 972 · see citing works
Nitsch, R. M., Slack, B. E., Wurtman, R. J., & Growdon, J. H. (1992) · Science · doi:10.1126/science.1411529 · Cited by 898 · see citing works
Uta Frith, A., & Mira, M. P. (1992) · Focus on Autism and Other Developmental Disabilities · doi:10.1177/108835769200700302 · Cited by 889 · see citing works
Neuronal nicotinic receptors in the human brain
Paterson, D., & Nordberg, A. K. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 782 · see citing works
Nicotine activates and desensitizes midbrain dopamine neurons
Pidoplichko, V. I., DeBiasi, M., Williams, J. T., & Dani, J. A. (1997) · Nature · doi:10.1038/37120 · Cited by 769 · see citing works
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
Perry, E. K., Walker, M. P., Grace, J., & Perry, R. H. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01361-7 · Cited by 764 · see citing works
Self-citationSchizophrenia, sensory gating, and nicotinic receptors
Adler, L. E., Olincy, A., Waldo, M., Harris, J. G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S., et al. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033320 · Cited by 690 · see citing works
Neuroleptic sensitivity in patients with senile dementia of Lewy body type.
McKeith, I., Fairbairn, A., Perry, R., Thompson, P. M., & Perry, E. (1992) · British medical journal · doi:10.1136/bmj.305.6855.673 · Cited by 687 · see citing works
Self-citationNormalization of auditory physiology by cigarette smoking in schizophrenic patients
Adler, L. E., Hoffer, L., Wiser, A., & Freedman, R. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679 · see citing works
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678 · see citing works
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain
Picciotto, M. R., Zoli, M., Léna, C., Bessis, A., Lallemand, Y., LeNovère, N., Vincent, P., Pich, E. M., Brûlet, P., & Changeux, J.-P. (1995) · Nature · doi:10.1038/374065a0 · Cited by 668 · see citing works
Environmental risk factors and Parkinson's disease
Liou, H., Tsai, M.-C., Chen, C., Jeng, J., Chang, Y. C., Chen, S. Y., & Chen, R.-T. (1997) · Neurology · doi:10.1212/wnl.48.6.1583 · Cited by 616 · see citing works
Senile dementia of Lewy body type
Perry, R. H., Irving, D., Blessed, G., FAIRBAIRN, A. F., & Perry, E. K. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90236-g · Cited by 573 · see citing works
Self-citationAlkondon, M., & Albuquerque, E. X. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38283-2 · Cited by 538 · see citing works
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Jiménez, M. D. M. A., Cordero‐Erausquin, M., Léna, C., Novère, N. G. L., d’Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J. (1999) · Nature · doi:10.1038/19756 · Cited by 533 · see citing works
Jones, G., Sahakian, B. J., Levy, R., Warburton, D. M., & Gray, J. A. (1992) · Psychopharmacology · doi:10.1007/bf02247426 · Cited by 476 · see citing works
Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors
Vernino, S. A., Amador, M., Luetje, C. W., Patrick, J., & Dani, J. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90114-s · Cited by 468 · see citing works
The cerebral cortex of the rat
(1991) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(91)90172-9 · Cited by 416 · see citing works
Human neuronal nicotinic receptors
Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 413 · see citing works
Plaisted, K., Swettenham, J., & Rees, L. (1999) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00489 · Cited by 409 · see citing works
Eisenberg, L. (1992) · The Lancet · doi:10.1016/0140-6736(92)90257-4 · Cited by 401 · see citing works
Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04461.1998 · Cited by 401 · see citing works
Cholinergic Activity in Autism: Abnormalities in the Cerebral Cortex and Basal Forebrain
Perry, E. K., Lee, M., Martin-Ruiz, C. M., COURT, J. A., Volsen, S. G., Merrit, J., Folly, E. A., Iversen, P. E., Bauman, M. L., Perry, R. H., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1058 · Cited by 390 · see citing works
Self-citationIdentification of four classes of brain nicotinic receptors using beta2 mutant mice.
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · PubMed Central · doi:10.1523/jneurosci.18-12-04461.1996 · Cited by 387 · see citing works
Perry, E. K., Morris, C. M., COURT, J. A., Cheng, A. V., FAIRBAIRN, A. F., McKeith, I. G., Irving, D., Brown, A. J., & Perry, R. H. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00410-7 · Cited by 386 · see citing works
Self-citationLe Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385 · see citing works
Cigarette smoking and protection from Parkinson's disease
Morens, D. M., Grandinetti, A., REED, D. M., White, L. R., & Ross, G. W. (1995) · Neurology · doi:10.1212/wnl.45.6.1041 · Cited by 368 · see citing works
Bannon, A. W., Decker, M. W., Holladay, M. W., Curzon, P., Donnelly‐Roberts, D. L., Puttfarcken, P. S., Bitner, R. S., Díaz, Á., Dickenson, A. H., Porsolt, R. D., et al. (1998) · Science · doi:10.1126/science.279.5347.77 · Cited by 368 · see citing works
The paradox of nicotinic acetylcholine receptor upregulation by nicotine
Wonnacott, S. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90242-z · Cited by 357 · see citing works
Mulle, C., Choquet, D., Korn, H., & Changeux, J. (1992) · Neuron · doi:10.1016/0896-6273(92)90115-t · Cited by 351 · see citing works
Jellinger, K. A. (1999) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6360-3_1 · Cited by 349 · see citing works
Assembly of Human Neuronal Nicotinic Receptor α5 Subunits with α3, β2, and β4 Subunits
Wang, F., Gerzanich, V., Wells, G. B., Anand, R., Peng, X.-D., Keyser, K. T., & Lindstrom, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17656 · Cited by 345 · see citing works
Lohr, J. B., & FLYNN, K. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90024-y · Cited by 340 · see citing works
Plaisted, K. C., Swettenham, J., & Rees, L. (1999) · Journal of Child Psychology and Psychiatry · doi:10.1017/s0021963099004102 · Cited by 340 · see citing works
Fenster, C. P., Rains, M. F., Noerager, B., Quick, M. W., & Lester, R. A. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05747.1997 · Cited by 332 · see citing works
Piggott, M. A., Marshall, E. F., Thomas, N., Lloyd, S. R., COURT, J. A., Jaros, E., Burn, D. J., Johnson, M. K., Perry, R. H., McKeith, I. G., et al. (1999) · Brain · doi:10.1093/brain/122.8.1449 · Cited by 330 · see citing works
Self-citationRapin, I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370206 · Cited by 319 · see citing works
Aubert, I., Araujo, D. M., Cécyre, D., Robitaille, Y., Gauthier, S. G., & Quirion, R. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09752.x · Cited by 317 · see citing works
Guan, Z., Zhang, X., Ravid, R., & Nordberg, A. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740237.x · Cited by 285 · see citing works
Marshall, D. L., Redfern, P. H., & Wonnacott, S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68041511.x · Cited by 284 · see citing works
Flynn, D. D., & Mash, D. C. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb13113.x · Cited by 284 · see citing works
Clarke, P. B. S., & Reuben, M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15232.x · Cited by 262 · see citing works
Changes in Nicotinic and Muscarinic Cholinergic Receptors in Alzheimer‐Type Dementia
Shimohama, S., Taniguchi, T., Fujiwara, M., & Kameyama, M. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb12960.x · Cited by 258 · see citing works
Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia
COURT, J. A., Spurden, D., Lloyd, S. R., McKeith, I. G., Ballard, C. G., Cairns, N. J., Kerwin, R. W., Perry, R., & Perry, E. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731590.x · Cited by 252 · see citing works
Self-citationNicotinic receptor abnormalities in Alzheimer’s disease
COURT, J. A., Martin-Ruiz, C. M., Piggott, M. A., Spurden, D., Griffiths, M., & Perry, E. K. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01116-1 · Cited by 232 · see citing works
Self-citationBreese, C. R., Adams, C. E., Logel, J., Drebing, C. J., Rollins, Y. D., Barnhart, M. M., Sullivan, B. F., DeMasters, B. K., Freedman, R., & Leonard, S. S. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971027)387:3 · Cited by 231 · see citing works
Trauth, J. A., Seidler, F. J., McCook, E. C., & Slotkin, T. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01994-0 · Cited by 230 · see citing works
Methyllycaconitine: a selective probe for neuronal α‐bungarotoxin binding sites
Ward, J. M., Cockcroft, V. B., Lunt, G. G., Smillie, F., & Wonnacott, S. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81231-c · Cited by 223 · see citing works
Prospective Study of Cigarette Smoking and the Risk of Developing Idiopathic Parkinson's Disease
Grandinetti, A., Morens, D. M., REED, D. M., & MacEachern, D. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116960 · Cited by 221 · see citing works
Neurofunctional mechanisms in autism
Waterhouse, L., Fein, D., & Modahl, C. (1996) · Psychological Review · doi:10.1037/0033-295x.103.3.457 · Cited by 218 · see citing works
Palma, E., Bertrand, S., Binzoni, T., & Bertrand, D. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021203 · Cited by 218 · see citing works
Bauman, M. L. (2006) · Johns Hopkins University Press eBooks · doi:10.1353/book.3225 · Cited by 215 · see citing works
Hellström‐Lindahl, E., Mousavi, M. T., Zhang, X., Ravid, R., & Nordberg, A. K. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00030-3 · Cited by 215 · see citing works
Cholinergic Transmitter and Neurotrophic Activities in Lewy Body Dementia
Perry, E. K., Irving, D., Kerwin, J. M., McKeith, I. G., Thompson, P., Collerton, D., FAIRBAIRN, A. F., Ince, P. G., Morris, C. M., Cheng, A. V., et al. (1993) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199307020-00002 · Cited by 213 · see citing works
Self-citationNordberg, A. K., Lundqvist, H., Hartvig, P., Lilja, A., & Långström, B. (1995) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199505000-00006 · Cited by 212 · see citing works
[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy
Bokobza, B., Ruberg, M., Scatton, B., Javoy-Agid, F., & Agid, Y. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90238-3 · Cited by 209 · see citing works
Biological Aspects of Alzheimer's Disease
(1984) · Journal of Gerontology · doi:10.1093/geronj/39.5.630a · Cited by 203 · see citing works
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases
Perry, E. K., Martin-Ruiz, C. M., Lee, M., Griffiths, M., Johnson, M., Piggott, M. A., Haroutunian, V. H., Buxbaum, J. D., Nãsland, J., Davis, K. L., et al. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00064-9 · Cited by 201 · see citing works
Self-citationA postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease
Rinne, J. O., ̈, T. M., Lönnberg, P., & Marjama¨ki, P. (1991) · Brain Research · doi:10.1016/0006-8993(91)90588-m · Cited by 195 · see citing works
Martin-Ruiz, C. M., COURT, J. A., Molnár, E., Lee, M., Gotti, C., Mamalaki, A., Tsouloufis, T., Tzartos, S. J., Ballard, C. G., Perry, R. H., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731635.x · Cited by 194 · see citing works
Self-citationDownregulation of nicotinic receptor function after chronic nicotine infusion.
Marks, M. J., Grady, S. R., & Collins, A. C. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39368-7 · Cited by 190 · see citing works
Burghaus, L., Schütz, U., Krempel, U., de Vos, R. A. I., Steur, E. N. H. J., Wevers, A., Lindstrom, J. M., & Schröder, H. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00031-0 · Cited by 178 · see citing works
Olale, F., Gerzanich, V., Kuryatov, A., Wang, F., & Lindstrom, J. M. (1997) · PubMed · Cited by 172 · see citing works
Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens
Damsma, G., Day, J. C., & Fibiger, H. C. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90798-x · Cited by 169 · see citing works
Benwell, M. E. M., Balfour, D. J. K., & Birrell, C. E. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13248.x · Cited by 169 · see citing works
Charpantier, E., Barnéoud, P., Moser, P. C., Besnard, F., & Sgard, F. (1998) · Neuroreport · doi:10.1097/00001756-199809140-00033 · Cited by 166 · see citing works
Cholinergic regulation of cortical development and plasticity. New twists to an old story.
Cf, H., & Berger-Sweeney, J. E. (1998) · PubMed · Cited by 165 · see citing works
Autism: recent molecular genetic advances
Lamb, J. A. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.861 · Cited by 163 · see citing works
Neuroreceptor changes in Alzheimer disease.
Nordberg, A. K. (1992) · PubMed · Cited by 160 · see citing works
Neuronal Nicotinic Receptor Subtypes
Lindstrom, J. M., Anand, R., Peng, X.-D., Gerzanich, V., Wang, F., & LI, Y. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17467.x · Cited by 160 · see citing works
Wevers, A., Monteggia, L. M., Nowacki, S., Bloch, W., Schütz, U., Lindstrom, J. M., Pereira, E. F. R., Eisenberg, H. M., Giacobini, E., de Vos, R. A. I., et al. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00676.x · Cited by 158 · see citing works
COURT, J. A., Piggott, M. A., Lloyd, S. R., Cookson, N., Ballard, C. G., McKeith, I. G., Perry, R. H., & Perry, E. K. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00071-3 · Cited by 156 · see citing works
Self-citationSensitization of the Mesoaccumbens Dopamine Response to Nicotine
Balfour, D. J. K., Benwell, M. E. M., Birrell, C. E., Kelly, J. T., & Al-Aloul, M. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00537-6 · Cited by 156 · see citing works
Nicotine may relieve symptoms of Parkinson's disease
Fagerström, K. O., Pomerleau, O. F., Giordani, B., & Stelson, F. W. (1994) · Psychopharmacology · doi:10.1007/bf02244882 · Cited by 155 · see citing works
Michele, G. D., Filla, A., Volpe, G., Marco, V. D., Gogliettino, A., Ambrosio, G., Marconi, R., Castellano, A., & Campanella, G. (1996) · Movement Disorders · doi:10.1002/mds.870110105 · Cited by 149 · see citing works
Cholinergic Receptors in Cognitive Disorders
Perry, E. K., Perry, R. H., Smith, C. J., Purohit, D. P., Bonham, J. R., Dick, D. J., Candy, J., Edwardson, J. A., & FAIRBAIRN, A. F. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037240 · Cited by 149 · see citing works
Self-citationNicotine psychopharmacology; molecular, cellular and behavioural aspects
Wonnacott, S. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90259-9 · Cited by 148 · see citing works
COURT, J. A., Lloyd, S. R., Johnson, M. H., Griffiths, M., Birdsall, N. J. M., Piggott, M. A., Oakley, A. E., Ince, P. G., Perry, E. K., & Perry, R. H. (1997) · Developmental Brain Research · doi:10.1016/s0165-3806(97)00052-7 · Cited by 146 · see citing works
Self-citationNicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease
Sugaya, K., Giacobini, E., & Chiappinelli, V. A. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270314 · Cited by 144 · see citing works
Flores, C. M., Dávila‐García, M. I., Ulrich‐Lai, Y. M., & Kellar, K. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052216.x · Cited by 142 · see citing works
Reductions in Acetylcholine and Nicotine Binding in Several Degenerative Diseases
Whitehouse, P. J., Martino, A. M., Marcus, K. A., Zweig, R. M., Singer, H. S., Price, D. L., & Kellar, K. J. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520310028012 · Cited by 141 · see citing works
Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients
D, A. O. M. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00095-x · Cited by 136 · see citing works
Ke, L., Eisenhour, C. M., Bencherif, M., & Lukas, R. J. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37658-x · Cited by 136 · see citing works
Court, J. A., Lloyd, S., Thomas, N., Piggott, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., & Perry, E. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00088-8 · Cited by 135 · see citing works
Self-citationDistribution of Nicotinic Receptors in the Human Hippocampus and Thalamus
Rubboli, F., COURT, J. A., Sala, C., Morris, C. M., Chini, B., Perry, E. K., & Clementi, F. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00550.x · Cited by 134 · see citing works
Self-citationThe fall and rise of neuronal α-bungarotoxin binding proteins
Clarke, P. B. S. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90125-p · Cited by 133 · see citing works
A RETROSPECTIVE STUDY OF SMOKING IN PARKINSON'S DISEASE1
Nefzger, M. D., QUADFASEL, F. A., & KARL, V. C. (1968) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120874 · Cited by 130 · see citing works
Grady, S. R., Marks, M. J., & Collins, A. C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62041390.x · Cited by 126 · see citing works
Lange, K. W., Wells, F. R., Jenner, P. G., & MARSDEN, C. D. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05838.x · Cited by 125 · see citing works
Perry, E. K., Smith, C. J., COURT, J. A., & Perry, R. H. (1990) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257646 · Cited by 124 · see citing works
Self-citationNicotine‐induced Protection Against Glutamate Cytotoxicity
Shimohama, S., AKAIKE, A., & Kimura, J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34445.x · Cited by 118 · see citing works
Effects of smoking in patients with early-onset Parkinson's disease
Ishikawa, A., & Miyatake, T. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90150-w · Cited by 115 · see citing works
Durany, N., Zöchling, R., Boissl, K. W., Paulus, W., Ransmayr, G. N., Tatschner, T., Danielczyk, W., Jellinger, K. A., Deckert, J., & Riederer, P. F. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01144-7 · Cited by 112 · see citing works
CNS Neurotransmitters and Neuromodulators: Dopamine
Stone, T. W. (1996) · Medical Entomology and Zoology · Cited by 106 · see citing works
Barrantes, G. E., Rogers, A. T., Lindstrom, J. M., & Wonnacott, S. (1995) · Brain Research · doi:10.1016/0006-8993(94)01386-v · Cited by 106 · see citing works
Nicotine for the treatment of Tourette's syndrome
Sanberg, P. R., Silver, A. A., Shytle, R. D., Philipp, M. K., Cahill, D. W., Fogelson, H. M., & McConville, B. J. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00199-4 · Cited by 106 · see citing works
Trouslard, J., Marsh, S. J., & Brown, D. A. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019759 · Cited by 100 · see citing works
Chini, B., Raimond, E., Elgoyhen, A. B., Moralli, D., Balzaretti, M., & Heinemann, S. (1994) · Genomics · doi:10.1006/geno.1994.1075 · Cited by 99 · see citing works
Postmortem stability of α-bungarotoxin binding sites in mouse and human brain
Davies, P., & Feisullin, S. (1981) · Brain Research · doi:10.1016/0006-8993(81)90148-7 · Cited by 99 · see citing works
Marutle, A., Berglund, U. W., Bogdanović, N., & Nordberg, A. K. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00558-7 · Cited by 96 · see citing works
Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain
Mo, J. Q., Hom, D. G., & Andersen, J. K. (1995) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(95)01586-o · Cited by 96 · see citing works
Mcconville, B. J., Sanberg, P. R., Fogelson, M. H., King, J., Cirino, P. T., Parker, K. W., & Norman, A. B. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90315-q · Cited by 94 · see citing works
Huppert, F. A., Brayne, C., & O’Connor, D. (1994) · Cambridge University Press eBooks · Cited by 93 · see citing works
Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging
Hellström‐Lindahl, E., & COURT, J. A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00210-2 · Cited by 92 · see citing works
Self-citationRogers, S. W., Gahring, L. C., Collins, A. C., & Marks, M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04825.1998 · Cited by 91 · see citing works
Immunohisto- and cytochemical localization of cortical nicotinic cholinoceptors in rat and man
Schröder, H., Zilles, K., Maelicke, A., & Hajós, F. (1989) · Brain Research · doi:10.1016/0006-8993(89)90624-0 · Cited by 90 · see citing works
Yu, Z. J., & Wecker, L. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63010186.x · Cited by 90 · see citing works
THE ROLE OF THE NUCLEUS BASALIS OF MEYNERT IN DEMENTIA: REVIEW AND RECONSIDERATION
Cummnings, J. L., & Benson, D. F. (1987) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198701030-00003 · Cited by 88 · see citing works
Smoking and Parkinson's disease: a case-control study in Germany
Hellenbrand, W., Seidler, A., Robra, B., Vieregge, P., Oertel, W. H., Joerg, J., NISCHAN, P., Schneider, E., & Ulm, G. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.2.328 · Cited by 87 · see citing works
Hsu, Y., Αmin, J., Weiss, D. S., & Wecker, L. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020667.x · Cited by 87 · see citing works
Morphological substrates of dementia in parkinsonism A critical update
Jellinger, K. A. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_6 · Cited by 85 · see citing works
Nicotine modulates the neurotoxic effect of β-amyloid protein(25–35) in hippocampal cultures
Zamani, R., Allen, Y. S., Owen, G. P., & Gray, J. A. (1997) · Neuroreport · doi:10.1097/00001756-199701200-00027 · Cited by 85 · see citing works
Kiba, H., & Jayaraman, A. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90205-4 · Cited by 84 · see citing works
Nitsch, R. M., Deng, A., Wurtman, R. J., & Growdon, J. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020704.x · Cited by 84 · see citing works
Evidence for Functional Activity of Up‐Regulated Nicotine Binding Sites in Rat Striatal Synaptosomes
Rowell, P. P., & Wonnacott, S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05802.x · Cited by 84 · see citing works
Nicotinic Acetylcholine Receptors in Alzheimer's Disease
Wevers, A., & Schröder, H. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-14-503 · Cited by 84 · see citing works
Belluardo, N., Blum, M., Mudò, G., Andbjer, B., & Fuxé, K. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00323-0 · Cited by 83 · see citing works
Spurden, D., COURT, J. A., Lloyd, S. R., Oakley, A. E., Perry, R., Pearson, C., Pullen, R. G. L., & Perry, E. K. (1997) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(97)00038-0 · Cited by 76 · see citing works
Self-citationMolinari, E. J., Delbono, O., Messi, M. L., Renganathan, M., Arnerić, S. P., Sullivan, J. P., & Gopalakrishnan, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00084-3 · Cited by 75 · see citing works
Wevers, A., Jeske, A., Lobron, C., Birtsch, C., Heinemann, S., Maelicke, A., Schröder, R., & Schröder, H. C. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90286-0 · Cited by 72 · see citing works
Potential Role of Muscarinic Agonists in Alzheimerʼs Disease
Avery, E., Baker, L. D., & Asthana, S. (1997) · Drugs & Aging · doi:10.2165/00002512-199711060-00004 · Cited by 71 · see citing works
Rowell, P. P., & Hillebrand, J. A. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020561.x · Cited by 70 · see citing works
Nicotine psychopharmacology; molecular, cellular and behavioural aspects
Wonnacott, S. (1991) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(91)90222-x · Cited by 68 · see citing works
Mattson, M. P. (1996) · PubMed · Cited by 67 · see citing works
Tordjman, S., Antoine, C., Cohen, D. J., Gauvain‐Piquard, A., Carlier, M., Roubertoux, P. L., & Ferrari, P. (1999) · PubMed · Cited by 65 · see citing works
Nabilone increases choreatic movements in Huntington's disease
Müller‐Vahl, K., Schneider, U., & Emrich, H. M. (1999) · Movement Disorders · doi:10.1002/1531-8257(199911)14:6 · Cited by 65 · see citing works
Smoking and Parkinson's disease
Tzourio, C., Rocca, W. A., Breteler, M. M. B., Baldereschi, M., Dartigues, J.-F., Pousa, S. L., Manubens-Bertran, J. M., Alpérovitch, A., & the EUROPARKINSON Study Group (1997) · Neurology · doi:10.1212/wnl.49.5.1267 · Cited by 63 · see citing works
Falk, W. E. (1995) · Psychosomatics · doi:10.1016/s0033-3182(95)71617-6 · Cited by 61 · see citing works
Xuereb, J. H., Perry, E. K., Candy, J., Bonham, J. R., Perry, R. H., & Marshall, E. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90155-g · Cited by 61 · see citing works
Self-citationMarks, M. J., Grady, S. R., Yang, J., Lippiello, P. M., & Collins, A. C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062125.x · Cited by 61 · see citing works
Apoptosis and Oxidative Stress in the Aging Brain
Adams, J. D., Jr., Mukherjee, S. K., Klaidman, L. K., CHANG, M. L., & Yasharel, R. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39058.x · Cited by 60 · see citing works
Chen, Y., Ögren, S. O., Bjelke, B., Bolme, P., Eneroth, P. H. E., Gross, J. P., Loidl, F., Herrera‐Marschitz, M., & Anderssn, K. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00118-3 · Cited by 58 · see citing works
The Aging brain : cellular and molecular mechanisms of aging in the nervous system
Giacobini, E. (1982) · Raven Press eBooks · Cited by 57 · see citing works
Tohgi, H., Utsugisawa, K., Yoshimura, M., Nagane, Y., & Mihara, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00205-5 · Cited by 57 · see citing works
Variations of monoamines and their metabolites in the human brain putamen
Konradi, C. L., Kornhuber, J., Sofic, E., Heckers, S., Riederer, P. F., & Beckmann, H. (1992) · Brain Research · doi:10.1016/0006-8993(92)90062-e · Cited by 55 · see citing works
CNS Neurotransmitters and Neuromodulators
Stone, T. W. (2020) · CRC Press eBooks · doi:10.1201/9781003068723 · Cited by 54 · see citing works
Sihver, W., Gillberg, P.-G., Svensson, A., & Nordberg, A. K. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00295-x · Cited by 53 · see citing works
Expression of the α3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease
Terzano, S., Court, J. A., Fornasari, D., Griffiths, M., Spurden, D., Lloyd, S. R., Perry, R. H., Perry, E. K., & Clementi, F. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00260-5 · Cited by 51 · see citing works
Self-citationBrain Nicotinic and Muscarinic Receptors in Normal Aging and Dementia
Nordberg, A. K., & Winblad, B. G. (1986) · Advances in behavioral biology · doi:10.1007/978-1-4613-2179-8_12 · Cited by 48 · see citing works
Perry, E. K., COURT, J. A., Johnson, M., Piggott, M. A., & Perry, R. H. (1992) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(92)90056-v · Cited by 47 · see citing works
Self-citationDURSUN, S. M., & Reveley, M. A. (1997) · Psychological Medicine · doi:10.1017/s0033291796003984 · Cited by 46 · see citing works
Serum antibodies to nicotinic acetylcholine receptors in schizophrenic patients
Mukherjee, S., Mahadik, S. P., Korenovsky, A., Laev, H., Schnur, D. B., & Reddy, R. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90070-1 · Cited by 44 · see citing works
Kem, W. R. (1997) · Invertebrate Neuroscience · doi:10.1007/bf02480382 · Cited by 43 · see citing works
Martin-Ruiz, C. M., Piggott, M. A., Gotti, C., Lindstrom, J. M., Mendelow, A. D., Siddique, M. S., Perry, R. H., Perry, E. K., & COURT, J. A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00110-6 · Cited by 43 · see citing works
Self-citationNeocortical Cholinergic Enzyme and Receptor Activities in the Human Fetal Brain
Perry, E. K., Smith, C. J., Atack, J. R., Candy, J. M., Johnson, M., & Perry, R. H. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00749.x · Cited by 41 · see citing works
Self-citationAttenuation of β‐Amyloid Neurotoxicity In Vitro by Potassium‐Induced Depolarization
Pike, C. J., Balázs, R., & Cotman, C. W. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041774.x · Cited by 41 · see citing works
Tönnes, J., Stierli, B., Cerletti, C., Behrmann, J. T., Molnár, E., & Streit, P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.02195.x · Cited by 41 · see citing works
Gotti, C., Briscini, L., Verderio, C., Oortgiesen, M., Balestra, B., & Clementi, F. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00630.x · Cited by 39 · see citing works
Parks, R. W., Becker, R. E., Rippey, R. F., Gilbert, D. G., Matthews, J. R., Kabatay, E., Young, C. S., Vohs, C., Danz, V., Keim, P., et al. (1996) · Neuropsychology Review · doi:10.1007/bf01875368 · Cited by 39 · see citing works
Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons
Prasad, C., Ikegami, H., Shimizu, I., & Onaivi, E. S. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00839-6 · Cited by 39 · see citing works
Alzheimer’s and Parkinson’s Disease: Strategies in Research and Development
Hanin, I. (1986) · Advances in behavioral biology · doi:10.1007/978-1-4613-2179-8_75 · Cited by 39 · see citing works
Tohgi, H., Utsugisawa, K., Yoshimura, M., Nagane, Y., & Mihara, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00093-6 · Cited by 37 · see citing works
Elliott, K. J., Jones, J. M., Sacaan, A. I., Lloyd, G. K., & Corey-Naeve, J. (1998) · Journal of Molecular Neuroscience · doi:10.1007/bf02761778 · Cited by 34 · see citing works
Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease
Sabbagh, M. N., Reid, R. T., Corey‐Bloom, J., Rao, T. S., Hansen, L. A., Alford, M. F., Masliah, E., Adem, A., Lloyd, G. K., & Thal, L. J. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050090 · Cited by 34 · see citing works
Janson, A. M., Fuxé, K., Agnati, L. F., Jansson, A., Bjelke, B., Sundström, E., Andersson, K., Härfstrand, A., Goldstein, M., & Owmand, C. (1989) · Progress in brain research · doi:10.1016/s0079-6123(08)62485-1 · Cited by 33 · see citing works
Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics
̈m-Lindahl, E. H., Winblad, B. G., & Nordberg, A. K. (1993) · Brain Research · doi:10.1016/0006-8993(93)90268-r · Cited by 32 · see citing works
COURT, J. A., Perry, E. K., Spurden, D., Lloyd, S. R., Gillespie, J., Whiting, P. J., & Barlow, R. B. (1994) · Brain Research · doi:10.1016/0006-8993(94)91721-3 · Cited by 31 · see citing works
Self-citationUtsugisawa, K., Nagane, Y., Tohgi, H., Yoshimura, M., Ohba, H., & Genda, Y. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00473-5 · Cited by 31 · see citing works
Localization of mRNA for CHRNA7 in human fetal brain.
Agulhon, C., Abitbol, M. M., Bertrand, D., & Malafosse, A. (1999) · PubMed · Cited by 31 · see citing works
Sparks, D. L., Beach, T. G., & Lukas, R. J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00794-0 · Cited by 29 · see citing works
Grenhoff, J., Janson, A. M., Svensson, T. H., & Fuxé, K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90646-d · Cited by 25 · see citing works
Audesirk, T., & Cabell, L. (1999) · PubMed · Cited by 25 · see citing works
Hu, M., Bigger, C. B., & Gardner, P. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4497 · Cited by 23 · see citing works
Neurotransmitter regulation of neuronal outgrowth, plasticity and survival in the year 2001
Kater, S. B., & Lipton, S. A. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80025-w · Cited by 22 · see citing works
Nanri, T., Kasahara, N., Yamamoto, J., Miyake, H., & Watanabe, H. (1998) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.78.385 · Cited by 21 · see citing works
Abdulla, F. A., Calaminici, M., Wonnacott, S., Gray, J. A., Stephenson, J. D., & Sinden, J. D. (1995) · Synapse · doi:10.1002/syn.890210402 · Cited by 20 · see citing works
Diagnosis, treatment, and neurobiology of autism in children
Lainhart, J. E., & Piven, J. (1995) · Current Opinion in Pediatrics · doi:10.1097/00008480-199508000-00009 · Cited by 19 · see citing works
Nicotinic cholinergic receptors in Alzheimer’s disease
Kellar, K. J., & Wonnacott, S. (1990) · doi:10.1093/oso/9780192616142.003.0010 · Cited by 19 · see citing works
de la Torre, J. C., Nelson, N., Sutherland, R. J., & Pappas, B. A. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01169-4 · Cited by 18 · see citing works
Wevers, A., Sullivan, J. P., Giordano, T., Birtsch, C., Monteggia, L. M., Nowacki, S., Arnerić, S. P., & Schröder, H. C. (1995) · Drug Development Research · doi:10.1002/ddr.430360205 · Cited by 18 · see citing works
Court, J., Piggott, M., Perry, E. K., Rb, B., & Perry, R. (1992) · Newcastle University ePrints (Newcastle Univesity) · doi:10.25405/ncl.34172580 · Cited by 16 · see citing works
Self-citationSocci, D. J., & Arendash, G. W. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815110 · Cited by 14 · see citing works
Neurotransmitter regulation of neuronal outgrowth, plasticity and survival in the year 2001
Kater, S. B. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93877-z · Cited by 10 · see citing works
Determinants of nicotine self-administration
Shoaib, M. C. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(199607/08)38:3/4 · Cited by 7 · see citing works
Aubert, I., Cécyre, D., Gauthier, S. G., & Quirion, R. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7445-8_47 · Cited by 5 · see citing works
Flagged first, then by citations
2 of the 186 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Levin, E. D., McClernon, F. J., & Rezvani, A. H. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0164-7 · Cited by 820 · see citing works
Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 669 · see citing works
The dynamic effects of nicotine on the developing brain
Dwyer, J. B., McQuown, S. C., & Leslie, F. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.003 · Cited by 559 · see citing works
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 525 · see citing works
Belmonte, M. K., Cook, E. H., Anderson, G. M., Rubenstein, J. L. R., Greenough, W. T., Beckel-Mitchener, A., Courchesne, E., Boulanger, L. M., Powell, S. B., Levitt, P. R., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001499 · Cited by 442 · see citing works
Self-citationCellular and synaptic mechanisms of nicotine addiction
Mansvelder, H. D., & McGehee, D. S. (2002) · Journal of Neurobiology · doi:10.1002/neu.10148 · Cited by 438 · see citing works
Smoking, nicotine and Parkinson's disease
Quik, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.008 · Cited by 323 · see citing works
Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection
Egea, J., Buendía, I., Parada, E., Navarro, E., Leon, R. M., & López, M. G. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.032 · Cited by 298 · see citing works
Functional brain imaging of tobacco use and dependence
BRODY, A. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.04.012 · Cited by 207 · see citing works
Pimlott, S. L., Piggott, M. A., Owens, J., Greally, E., COURT, J. A., Jaros, E., Perry, R. H., Perry, E. K., & Wyper, D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300302 · Cited by 170 · see citing works
Self-citationA critical review of neonicotinoid insecticides for developmental neurotoxicity
Sheets, L. P., Li, A. A., Minnema, D. J., Collier, R. H., Creek, M. R., & Peffer, R. C. (2015) · Critical Reviews in Toxicology · doi:10.3109/10408444.2015.1090948 · Cited by 156 · see citing works
Nicotine and Parkinson's disease: implications for therapy
Quik, M., O'Leary, K., & Tanner, C. M. (2008) · Movement Disorders · doi:10.1002/mds.21900 · Cited by 154 · see citing works
Nicotinic–serotonergic interactions in brain and behaviour
Seth, P., Cheeta, S., Tucci, S., & File, S. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00715-8 · Cited by 145 · see citing works
Therapeutic Potential of α7 Nicotinic Acetylcholine Receptors
Bertrand, D., Lee, C., Flood, D. G., Marger, F., & Donnelly‐Roberts, D. L. (2015) · Pharmacological Reviews · doi:10.1124/pr.113.008581 · Cited by 139 · see citing works
Acetylcholinesterase and Butyrylcholinesterase – Important Enzymes of Human Body
Patočka, J., Kuča, K., & Jun, D. (2004) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2018.95 · Cited by 137 · see citing works
Striatal α6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson’s Disease Therapy
Quik, M., & McIntosh, J. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094375 · Cited by 127 · see citing works
Gotti, C., Moretti, M., Bohr, I. J., Ziabreva, I., Vailati, S., Longhi, R., Riganti, L., Gaimarri, A., McKeith, I. G., Perry, R. H., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.005 · Cited by 126 · see citing works
Self-citationFunction of Partially Duplicated Human α7 Nicotinic Receptor Subunit CHRFAM7A Gene
de Lucas‐Cerrillo, A. M., Maldifassi, M. C., Arnalich, F., Renart, J., Atienza, G., Serantes, R., Cruces, J., Sánchez‐Pacheco, A., Andrés‐Mateos, E., & Montiel, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180067 · Cited by 123 · see citing works
Alzheimer's disease and anaesthesia: implications for the central cholinergic system
Fodale, V., Quattrone, D., Trecroci, C., Caminiti, V., & Santamaria, L. B. (2006) · British Journal of Anaesthesia · doi:10.1093/bja/ael233 · Cited by 121 · see citing works
Nicotinic receptors as CNS targets for Parkinson's disease
Quik, M., Bordia, T., & O’Leary, K. T. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.015 · Cited by 116 · see citing works
Brunzell, D. H., & McIntosh, J. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.299 · Cited by 114 · see citing works
Kimes, A. S., Horti, A. G., London, E. D., Chefer, S. I., Contoreggi, C. S., Monique Ernst, D., Friello, P. J., Koren, A. O., Kurian, V., Matochik, J. A., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0492fje · Cited by 113 · see citing works
Romanelli, M. N., & Gualtieri, F. (2003) · Medicinal Research Reviews · doi:10.1002/med.10037 · Cited by 112 · see citing works
Kawamata, J., & Shimohama, S. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110173 · Cited by 111 · see citing works
Nicotinic actions on neuronal networks for cognition: General principles and long-term consequences
Poorthuis, R. B., Goriounova, N. A., Couey, J. J., & Mansvelder, H. D. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.031 · Cited by 102 · see citing works
Alpha7 nicotinic acetylcholine receptor: A link between inflammation and neurodegeneration
Conejero‐Goldberg, C., Davies, P., & Ulloa, L. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.10.007 · Cited by 100 · see citing works
Developmental Excitation of Corticothalamic Neurons by Nicotinic Acetylcholine Receptors
Kassam, S. M., Herman, P. M., Goodfellow, N. M., Alves, N. C., & Lambe, E. K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2645-08.2008 · Cited by 100 · see citing works
Han, Z., Zoli, M., Cardona, A., Bourgeois, J., Changeux, J., & Novère, N. G. L. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10659 · Cited by 99 · see citing works
Nicotinic Receptor-Mediated Neuroprotection in Neurodegenerative Disease Models
Shimohama, S. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.332 · Cited by 99 · see citing works
In vivo Brain Imaging of Human Exposure to Nicotine and Tobacco
Sharma, A., & Brody, A. L. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_6 · Cited by 88 · see citing works
Ding, Y., Fowler, J. S., Logan, J., Wang, G., Telang, F., Garza, V., Biegon, A. R., Pareto, D., Rooney, W. D., Shea, C. E., et al. (2004) · Synapse · doi:10.1002/syn.20051 · Cited by 89 · see citing works
Scientific Opinion on the developmental neurotoxicity potential of acetamiprid and imidacloprid
(PPR), E. P. O. P. P. P. A. T. R. (2013) · EFSA Journal · doi:10.2903/j.efsa.2013.3471 · Cited by 97 · see citing works
Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes
Turner, J. R., & Kellar, K. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2112-05.2005 · Cited by 89 · see citing works
The role of astrocytic α7 nicotinic acetylcholine receptors in Alzheimer disease
Fontana, I. C., Kumar, A., & Nordberg, A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00792-4 · Cited by 86 · see citing works
Quik, M., Vailati, S., Bordia, T., Kulak, J. M., Fan, H., McIntosh, J. M., Clementi, F., & Gotti, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.006015 · Cited by 86 · see citing works
Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum
Graham, A., COURT, J. A., Martin-Ruiz, C. M., Jaros, E., Perry, R., Volsen, S. G., Bose, S., Evans, N. M., Ince, P. G., Kuryatov, A., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00223-3 · Cited by 85 · see citing works
Self-citationDifferential nicotinic acetylcholine receptor subunit expression in the human hippocampus
Graham, A. J., Ray, M. A., Perry, E. K., Jaros, E., Perry, R. H., Volsen, S. G., Bose, S., Evans, N. M., Lindstrom, J. M., & COURT, J. A. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(02)00100-x · Cited by 85 · see citing works
Self-citationQuik, M., Sum, J., Whiteaker, P., McCallum, S. E., Marks, M. J., Musachio, J. L., McIntosh, J. M., Collins, A. C., & Grady, S. R. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1169 · Cited by 83 · see citing works
Falk, L. L., Nordberg, A. K., Seiger, Å., Kjældgaard, A., & Hellström‐Lindahl, E. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.049 · Cited by 82 · see citing works
Huey, R., Hawthorne, S. J., & McCarron, P. A. (2016) · Journal of drug targeting · doi:10.1080/1061186x.2016.1223676 · Cited by 76 · see citing works
Cyto- and receptor architectonic mapping of the human brain
Palomero‐Gallagher, N., & Zilles, K. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63639-3.00024-4 · Cited by 74 · see citing works
Wong, D. F., Kuwabara, H., Pomper, M. G., Holt, D. P., Brašić, J. R., George, N., Фролов, Б. А., Willis, W. D., Gao, Y., Valentine, H., et al. (2014) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0779-3 · Cited by 73 · see citing works
O'Brien, J. T., Colloby, S. J., Pakrasi, S., Perry, E. K., Pimlott, S. L., Wyper, D., McKeith, I. G., & Williams, E. D. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.108209 · Cited by 73 · see citing works
Self-citationLifetime cigarette smoking is associated with striatal volume measures
Das, D., Cherbuin, N., Anstey, K. J., Sachdev, P. S., & Easteal, S. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00301.x · Cited by 72 · see citing works
Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia
Wallace, T. L., & Bertrand, D. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.736498 · Cited by 72 · see citing works
Inattentiveness, parental smoking and adolescent smoking initiation
Barman, S. K., Pulkkinen, L., Kaprio, J. A., & Rose, R. J. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00789.x · Cited by 72 · see citing works
Loss of α‐conotoxinMII‐ and A85380‐sensitive nicotinic receptors in Parkinson's disease striatum
Quik, M., Bordia, T., Forno, L. S., & McIntosh, J. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02177.x · Cited by 62 · see citing works
The potential role of cotinine in the cognitive and neuroprotective actions of nicotine
Buccafusco, J. J., & Terry, A. V. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00226-1 · Cited by 62 · see citing works
Nicotinic receptor subtypes in human brain related to aging and dementia
Perry, E. K., Martin-Ruiz, C. M., & COURT, J. A. (2001) · Alcohol · doi:10.1016/s0741-8329(01)00130-6 · Cited by 62 · see citing works
Self-citationPET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders
Tiepolt, S., Meyer, P., Patt, M., Deuther‐Conrad, W., Hesse, S., Barthel, H., & Sabri, O. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263198 · Cited by 61 · see citing works
Oikawa, H., Nakamichi, N., Kambe, Y., Ogura, M., & Yoneda, Y. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20398 · Cited by 59 · see citing works
Rasch, B., Gais, S., & Born, J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.6 · Cited by 57 · see citing works
Effects of nicotine and mecamylamine on cognition in rhesus monkeys
Katner, S. N., Davis, S. A., Kirsten, A. J., & Taffe, M. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1804-z · Cited by 57 · see citing works
Teaktong, T., Graham, A. J., COURT, J. A., Perry, R. H., Jaros, E., Johnson, M., Hall, R., & Perry, E. K. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.06.015 · Cited by 56 · see citing works
Self-citationThe role of cortical cholinergic pre- and post-synaptic receptors in taste memory formation
Ramı́rez-Lugo, L., Miranda, M. I., Escobar, M. L., Espinosa, E., & Bermúdez‐Rattoni, F. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(02)00038-2 · Cited by 55 · see citing works
Yoo, J. H., Valdovinos, M. G., & Williams, D. C. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0322-8 · Cited by 53 · see citing works
Kulak, J. M., Sum, J., Musachio, J. L., McIntosh, J. M., & Quik, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00868.x · Cited by 53 · see citing works
Aliev, G. M., Li, Y., Palacios, H. H., & Obrenovich, M. E. (2011) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/157489011797376942 · Cited by 51 · see citing works
In SilicoModels for the Human α4β2 Nicotinic Acetylcholine Receptor
Haddadian, E. J., Cheng, M. H., Coalson, R. D., Xu, Y., & Tang, P. S. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp804868s · Cited by 48 · see citing works
Alzheimer’s Disease and Genetics of Inflammation: A Pharmacogenomic Vision
Vasto, S., Candore, G., Duro, G., Lio, D., Grimaldi, M. P., & Caruso, C. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.12.1735 · Cited by 46 · see citing works
Luhar, R. B., Sawyer, K. S., Gravitz, Z. R., Ruiz, S. M., & Oscar‐Berman, M. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s52298 · Cited by 43 · see citing works
Kulak, J. M., Musachio, J. L., McIntosh, J. M., & Quik, M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039347 · Cited by 43 · see citing works
Higher expression of α7 nicotinic acetylcholine receptors in human fetal compared to adult brain
Falk, L. L., Nordberg, A. K., Seiger, Å., Kjældgaard, A., & Hellström‐Lindahl, E. (2003) · Developmental Brain Research · doi:10.1016/s0165-3806(03)00063-4 · Cited by 42 · see citing works
Acetylcholinesterase inhibitors may improve myelin integrity
Bartzokis, G. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.020 · Cited by 41 · see citing works
Brunzell, D. H., McIntosh, J. M., & Papke, R. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12421 · Cited by 40 · see citing works
Synthesis and biodistribution of radiolabeled alpha 7 nicotinic acetylcholine receptor ligands.
Pomper, M. G., Phillips, E. D., Fan, H. S., McCarthy, D. J., Keith, R. A., Gordon, J. C., Scheffel, U., Dannals, R. F., & Musachio, J. L. (2005) · PubMed · Cited by 41 · see citing works
Suzuki, T., Ueta, K., Sugimoto, M., Uchida, I., & Mashimo, T. (2003) · Anesthesia & Analgesia · doi:10.1097/00000539-200302000-00028 · Cited by 39 · see citing works
Hung, S.-Y., Huang, W.-P., Liou, H., & Fu, W.-M. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.003 · Cited by 41 · see citing works
Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET
Mitkovski, S., Villemagne, V. L., Novakovic, K. E., O'Keefe, G. J., Tochon‐Danguy, H., Mulligan, R. S., Dickinson, K. L., Saunder, T., Grégoire, M., Bottlaender, M., et al. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.04.013 · Cited by 39 · see citing works
Microarray Technology and its Application on Nicotine Research
Li, M. D., Konu, Ö., Kane, J. K., & Becker, K. G. (2002) · Molecular Neurobiology · doi:10.1385/mn:25:3:265 · Cited by 38 · see citing works
Löscher, W., Potschka, H., Właź, P., Danysz, W., & Parsons, C. G. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01542-5 · Cited by 38 · see citing works
Horti, A. G. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.030 · Cited by 37 · see citing works
Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease
Hirao, K., Pontone, G. M., & Smith, G. S. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.010 · Cited by 37 · see citing works
Coughlin, J. M., Du, Y., Rosenthal, H. B., Slania, S., Koo, S. M., Park, A., Solomon, G., Vranešić, M., Antonsdottir, I. M., Speck, C. L., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.10.009 · Cited by 37 · see citing works
Deuther‐Conrad, W., Fischer, S., Hiller, A., Becker, G., Cumming, P. D., Xiong, G., Funke, U., Sabri, O., Peters, D., & Brust, P. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1808-y · Cited by 36 · see citing works
Scientific Opinion on the developmental neurotoxicity potential of acetamiprid and imidacloprid
Ockleford, C. (2013) · Cited by 36 · see citing works
COURT, J. A., Johnson, M., Religa, D., Keverne, J., Kalaria, R. N., Jaros, E., McKeith, I. G., Perry, R., Näslund, J., & Perry, E. K. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00674.x · Cited by 36 · see citing works
Self-citationIn vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer’s Disease
Nakaizumi, K., Ouchi, Y., Terada, T., Yoshikawa, E., Kakimoto, A., Isobe, T., Bunai, T., Yokokura, M., Suzuki, K., & Magata, Y. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170591 · Cited by 35 · see citing works
iPSC model of CHRFAM7A effect on α7 nicotinic acetylcholine receptor function in the human context
Ihnatovych, I., Nayak, T. K., Ouf, A., Süle, N., Birkaya, B. G., Chaves, L. D., Auerbach, A. L., & Szigeti, K. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0375-z · Cited by 34 · see citing works
Toyohara, J., Ishiwata, K., Sakata, M., Wu, J., Nishiyama, S., Tsukada, H., & Hashimoto, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008961 · Cited by 34 · see citing works
Neuronal α7 Nicotinic Receptors as a Target for the Treatment of Schizophrenia
Wallace, T. L., & Bertrand, D. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.08.003 · Cited by 33 · see citing works
Machaalani, R., Kashi, P. K., & Waters, K. A. (2010) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2010.05.009 · Cited by 32 · see citing works
Gmehlin, D., Kreisel, S. H., Bachmann, S., Weisbrod, M., & Thomas, C. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr067 · Cited by 32 · see citing works
Ogawa, M., Nishiyama, S., Tsukada, H., Hatano, K., Fuchigami, T., Yamaguchi, H., Matsushima, Y., Ito, K., & Magata, Y. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.11.007 · Cited by 31 · see citing works
Neurochemistry of consciousness: cholinergic pathologies in the human brain
Perry, E. K., & Perry, R. H. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45020-6 · Cited by 31 · see citing works
Self-citationNMR structure of the transmembrane domain of the n-acetylcholine receptor β2 subunit
Bondarenko, V., Tillman, T. S., Xu, Y., & Tang, P. S. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.04.014 · Cited by 30 · see citing works
In Vitro Imaging Techniques in Neurodegenerative Diseases
Långström, B., Andrén, P. E., Lindhe, Ö., Svedberg, M. M., & Hall, H. (2007) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0088-1 · Cited by 29 · see citing works
Shimohama, S., & Kawamata, J. (2018) · Springer eBooks · doi:10.1007/978-981-10-8488-1_8 · Cited by 30 · see citing works
Yohn, N. L., Turner, J. R., & Blendy, J. A. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.211706 · Cited by 28 · see citing works
Cholinergic system in schizophrenia: A systematic review and meta-analysis
Saint-Georges, Z., MacDonald, J., Al-Khalili, R., Hamati, R., Solmi, M., Keshavan, M. S., Tuominen, L. J., & Guimond, S. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03023-y · Cited by 30 · see citing works
Taslim, N., Al-Rejaie, S. S., & Dar, M. S. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.046 · Cited by 28 · see citing works
Kulak, J. M., & Schneider, J. S. (2004) · Brain Research · doi:10.1016/j.brainres.2003.10.062 · Cited by 28 · see citing works
Tanibuchi, Y., Wu, J., Toyohara, J., Fujita, Y., Iyo, M., & Hashimoto, K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.008 · Cited by 27 · see citing works
Impact of ageing on postsynaptic neuronal nicotinic neurotransmission in auditory thalamus
Sottile, S. Y., Ling, L. L., Cox, B. C., & Caspary, D. M. (2017) · The Journal of Physiology · doi:10.1113/jp274467 · Cited by 27 · see citing works
Tae, H., & Adams, D. J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106747 · Cited by 26 · see citing works
Smoking Cessation in Patients With Psychiatric Disorders
Gelenberg, A. J., de León, J., Evins, A. E., Parks, J., & Rigotti, N. A. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0109 · Cited by 26 · see citing works
Differential nicotinic receptor expression in monkey basal ganglia: Effects of nigrostriatal damage
Quik, M., Polonskaya, Y., McIntosh, J. M., & Kulak, J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00106-9 · Cited by 25 · see citing works
Liu, Q., Yu, K., Chang, Y., Lukas, R. J., & Wu, J. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00760.x · Cited by 25 · see citing works
Therapeutic Strategies Targeting Amyloid-β Receptors and Transporters in Alzheimer’s Disease
Lao, K., Zhang, R., Luan, J., Zhang, Y., & Gou, X. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200851 · Cited by 25 · see citing works
Arjmandi-Rad, S., Nieland, J. D., Goozee, K. G., & Vaseghi, S. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07114-y · Cited by 25 · see citing works
- Authors
- Court, J. A., Martin-Ruiz, C., Graham, A., & Perry, E.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Court, Jenny A.
- ORCID
- Martin-Ruiz, Carmen
- Venue
- Journal of Chemical Neuroanatomy
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 20
- Issue
- 3-4
- Pages
- 281-298
- ISSN
- 0891-0618 (ISSN-L)
- OpenAlex
- W1967131207
- Cited by
- 180
- References
- 186
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 9 · 2017: 2 · 2016: 6 · 2015: 8 · 2014: 5 · 2013: 6 · 2012: 8
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Journal of Chemical Neuroanatomy (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Eli Lilly and Company
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, human brain, receptor subunit expression, alpha4beta2 nAChR, alpha7 nAChR, brain development, brain aging, neurodegeneration, autism spectrum disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies
- MeSH terms
- Brain Chemistry, Brain Diseases, Humans, Receptors, Nicotinic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review